Li Qiang: Clinical Trials

1 trial sponsored by Li Qiang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1

Follow Li Qiang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma
Yttrium-90, HAIC - Hepatocellular Carcinoma (HCC)
Not applicableRecruitingLi Qiang2862026-08-012025-08-27

Conditions studied

Carcinoma, Hepatocellular (1)

Interventions

Yttrium-90 (1)

Countries

China (1)